EISAI GLOBAL CLINICAL DEVELOPMENT Trademark

Trademark Overview

On Thursday, July 14, 2005, a trademark application was filed for EISAI GLOBAL CLINICAL DEVELOPMENT with the United States Patent and Trademark Office. The USPTO has given the EISAI GLOBAL CLINICAL DEVELOPMENT trademark a serial number of 79015691. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, July 14, 2015. This trademark is owned by Eisai Co., Ltd.. The EISAI GLOBAL CLINICAL DEVELOPMENT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Testing, inspection or research of pharmaceuticals
eisai global clinical development

General Information

Serial Number79015691
Word MarkEISAI GLOBAL CLINICAL DEVELOPMENT
Filing DateThursday, July 14, 2005
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, July 14, 2015
Registration Number3187591
Registration DateTuesday, December 19, 2006
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 3, 2006

Trademark Statements

Disclaimer with Predetermined Text"GLOBAL CLINICAL DEVELOPMENT"
Goods and ServicesTesting, inspection or research of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 27, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEisai R&D Management Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type98 - Unknown
AddressJP
Party NameEisai R&D Management Co., Ltd.
Party Type21 - New Owner After Publication
Legal Entity Type99 - Other
AddressJP
Party NameEisai Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameEisai Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Friday, February 5, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, February 5, 2016DEATH OF INTERNATIONAL REGISTRATION
Friday, June 5, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, October 30, 2014GENERIC MADRID TRANSACTION SENT TO IB
Thursday, October 30, 2014GENERIC MADRID TRANSACTION CREATED
Tuesday, May 27, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 27, 2013CANCELLED SECTION 71
Saturday, September 1, 2007FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, July 26, 2007FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 26, 2007FINAL DISPOSITION PROCESSED
Tuesday, July 24, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, March 29, 2007CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, February 1, 2007NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, December 19, 2006REGISTERED-PRINCIPAL REGISTER
Thursday, November 2, 2006CHANGE OF OWNER RECEIVED FROM IB
Tuesday, October 3, 2006PUBLISHED FOR OPPOSITION
Wednesday, September 13, 2006NOTICE OF PUBLICATION
Saturday, August 5, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 4, 2006ASSIGNED TO LIE
Tuesday, July 25, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 25, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 20, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 20, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 3, 2006REFUSAL PROCESSED BY IB
Friday, February 10, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 9, 2006REFUSAL PROCESSED BY MPU
Wednesday, February 8, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 7, 2006NON-FINAL ACTION WRITTEN
Thursday, February 2, 2006ASSIGNED TO EXAMINER
Monday, October 24, 2005NEW APPLICATION ENTERED IN TRAM
Thursday, October 20, 2005SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

development clinical global eisai pharmaceuticals research inspection testing